UA94226C2 - Пептидные токсины как терапевтические средства - Google Patents
Пептидные токсины как терапевтические средстваInfo
- Publication number
- UA94226C2 UA94226C2 UAA200712912A UAA200712912A UA94226C2 UA 94226 C2 UA94226 C2 UA 94226C2 UA A200712912 A UAA200712912 A UA A200712912A UA A200712912 A UAA200712912 A UA A200712912A UA 94226 C2 UA94226 C2 UA 94226C2
- Authority
- UA
- Ukraine
- Prior art keywords
- independently
- disclosed
- composition
- matter
- expression vector
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 239000003053 toxin Substances 0.000 title abstract 3
- 231100000765 toxin Toxicity 0.000 title abstract 3
- 108700012359 toxins Proteins 0.000 title abstract 3
- 239000008280 blood Substances 0.000 title 1
- 210000004369 blood Anatomy 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 3
- 239000013604 expression vector Substances 0.000 abstract 2
- 201000006417 multiple sclerosis Diseases 0.000 abstract 2
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 201000004624 Dermatitis Diseases 0.000 abstract 1
- 208000009329 Graft vs Host Disease Diseases 0.000 abstract 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 201000004681 Psoriasis Diseases 0.000 abstract 1
- 201000001263 Psoriatic Arthritis Diseases 0.000 abstract 1
- 208000036824 Psoriatic arthropathy Diseases 0.000 abstract 1
- 206010052779 Transplant rejections Diseases 0.000 abstract 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 abstract 1
- 125000000539 amino acid group Chemical group 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 208000024908 graft versus host disease Diseases 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 206010025135 lupus erythematosus Diseases 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000000116 mitigating effect Effects 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US67434205P | 2005-04-22 | 2005-04-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA94226C2 true UA94226C2 (ru) | 2011-04-26 |
Family
ID=39898894
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA200712912A UA94226C2 (ru) | 2005-04-22 | 2006-04-18 | Пептидные токсины как терапевтические средства |
Country Status (3)
| Country | Link |
|---|---|
| CN (1) | CN101232903A (ru) |
| UA (1) | UA94226C2 (ru) |
| ZA (1) | ZA200709701B (ru) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5858932B2 (ja) * | 2010-02-04 | 2016-02-10 | モルフォテック， インコーポレイテッド | クロロトキシンポリペプチドおよびコンジュゲートならびにその使用 |
| AR081066A1 (es) * | 2010-04-02 | 2012-06-06 | Hanmi Holdings Co Ltd | Conjugado de insulina donde se usa un fragmento de inmunoglobulina |
| CN109106943B (zh) | 2018-11-05 | 2021-04-20 | 中国科学院上海有机化学研究所 | 抗癫痫的毒素Martentoxin及其应用 |
| CN117255798A (zh) * | 2021-03-23 | 2023-12-19 | 西兰制药公司 | Kv1.3阻断剂 |
| CN116813701B (zh) * | 2023-03-03 | 2024-09-24 | 广西大学 | 靶向肌肉型乙酰胆碱受体的肽分子及其制备方法、用途 |
-
2006
- 2006-04-18 UA UAA200712912A patent/UA94226C2/ru unknown
- 2006-04-18 CN CNA2006800223959A patent/CN101232903A/zh active Pending
-
2007
- 2007-11-12 ZA ZA200709701A patent/ZA200709701B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200709701B (en) | 2008-07-30 |
| CN101232903A (zh) | 2008-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2006116156A3 (en) | Toxin peptides with extended blood halflife | |
| TW200833840A (en) | Toxin peptide therapeutic agents | |
| Tang et al. | Practical chemical synthesis of atypical ubiquitin chains by using an isopeptide‐linked Ub isomer | |
| AU2024202618A1 (en) | Bicyclic peptide ligands specific for EphA2 | |
| MX336623B (es) | Peptidos penetradores de las celulas y usos de los mismos. | |
| Dinh et al. | Antimicrobial activity of doubly-stapled alanine/lysine-based peptides | |
| WO2005065239A3 (en) | Novel recombinant proteins with n-terminal free thiol | |
| WO2006056464A3 (en) | Compound with affinity for the cytotoxic t lymphocyte-associated antigen (ctla-4) | |
| MX2008001865A (es) | Proteinas de fusion de albumina. | |
| ATE239792T1 (de) | Ribosomen inaktivierende proteine enthaltende materialien, verfahren zu ihrer herstellung und ihre verwendung | |
| AU6912294A (en) | Immunotoxins comprising ribosome-inactivating proteins | |
| Schroll et al. | The use of 2, 2′‐dithiobis (5‐nitropyridine)(DTNP) for deprotection and diselenide formation in protected selenocysteine‐containing peptides | |
| Huang et al. | A novel solid-phase site-specific PEGylation enhances the in vitro and in vivo biostabilty of recombinant human keratinocyte growth factor 1 | |
| Tang et al. | Peptides in cosmetics: From pharmaceutical breakthroughs to skincare innovations | |
| EP1829889A2 (en) | Kahalalide f and related compounds | |
| Dittmann et al. | Native chemical ligation in dimethylformamide can be performed chemoselectively without racemization | |
| Youn et al. | High-yield production of biologically active mono-PEGylated salmon calcitonin by site-specific PEGylation | |
| Song et al. | PEGylation and HAylation via catechol: α-Amine-specific reaction at N-terminus of peptides and proteins | |
| Sharma et al. | Hybrid helices: motifs for secondary structure scaffolds in foldamers | |
| JPH03503178A (ja) | 改変形質転換成長因子αオリゴペプタイド及びその医薬組成物 | |
| Vézina-Dawod et al. | N-substituted arylsulfonamide building blocks as alternative submonomers for peptoid synthesis | |
| Arpicco et al. | Novel poly (ethylene glycol) derivatives for preparation of ribosome-inactivating protein conjugates | |
| Gellett et al. | Synthesis of the unnatural amino acid Nα-Nε-(ferrocene-1-acetyl)-l-lysine: A novel organometallic nuclease | |
| CA2581110A1 (en) | Peptides and apl-type derivatives of hsp60 and pharmaceutical compositions | |
| US20250376709A1 (en) | Papb as a bimoiety-dependent thioether installation tool |